Measurement of Arterial Activity on Routine FDG PET/CT Images Improves Prediction of Risk of Future CV EventsAmparo L. Figueroa, Ahmed Tawakol, Amr Abdelbaky et al.|JACC. Cardiovascular imaging|2013Cited by 332
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to <i>ANGPTL3</i> mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemiaDaniel Gaudet, Eunju Hurh, Joyce Kingsbury et al.|European Heart Journal|2020Cited by 276